PAK1 and acute myeloid leukemia: To better understand the role of PAK1 in AML, a selective non-ATP competitive PAK1 small molecule inhibitor IPA-3 (Rane and Minden, 2014; Yao et al., 2020) was used to suppress PAK1 expression.